CClinicalTrials.gg
CompletedNCT01317537Updated Mar 17, 2011

Using an Electronic Personal Health Record to Empower Patients With Hypertension

An interventional study of Electronic personal health record in Hypertension, sponsored by Augusta University. Completed at 1 site in United States. Open to participants aged 21 Years to 80 Years. Per ClinicalTrials.gov, last updated 2011-03-17.

Sponsored by Augusta University · Not applicable and Interventional

Phase
Not applicable
Study type
Interventional
Enrollment
445
Allocation
Randomized
Ages
21 Years to 80 Years
Sex
All
01

Study summary

Project Summary:

An electronic personal health record (ePHR) could maximize patient/clinician collaboration and consequently improve patient self-management and related health outcomes. The purpose of the proposed project is to examine the feasibility, acceptability, and impact of an ePHR that has been modified using a patient- and family-centered approach and incorporates the experiences, perspectives, and insights of patients and family members actually using the system. Comparison of patients with the ePHR intervention to a group of "care as usual" patients will be performed. The investigators Specific Aims are: (1) To improve the application of patient- and family-centered care elements in an existing ePHR, based on feedback from a pilot study of patients and their families. The modified ePHR will be tested in a pilot group of patients with hypertension and their families. (2) To implement and test the effectiveness of the modified ePHR with patients being treated for hypertension by a team of physicians, mid-level practitioners, nurse clinicians, and support staff in two ambulatory settings. Outcome measures will include patient activation and perception of care, quantifiable biological markers, patient-physician communication, and congruence of treatment with guidelines, particularly medication management; (3) To monitor the shift in provider and support staff awareness and incorporation of patient- and family-centered care as a result of implementation of the ePHR using questionnaires and focus groups. If successful, this ePHR could be implemented in additional locations in the Southeast.

02

Conditions studied

  • Hypertension

Browse trials for

Keywords

  • personal health records
03

In context

Hypertension

6,689 studies on the registry are indexed under Hypertension; 965 are open to participants now.

This study's enrollment of 445 is above the median of 90 across 4,995 interventional studies indexed under Hypertension.

Browse Hypertension studies →

Lead sponsor

Augusta University is the lead sponsor of 177 studies on the registry; 24 are open to participants now.

Of its 10 completed or terminated interventional studies of FDA-regulated products, 3 (30%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
21 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • age 21
  • hypertension
  • referral by physician

Exclusion criteria

Exclusion Criteria:

  • age over 80
  • no hypertension
  • too ill to participate
05

Study design

Phase
Not applicable
Allocation
Randomized
Intervention model
Factorial assignment
Masking
Single (Investigator)
Enrollment
445 participants (actual)

Study arms

  • Experimental
    Received personal health record

    received personal health record access

    Other: Electronic personal health record

  • No intervention
    No personal health record

    did not receive personal health record

Interventions

  • OtherElectronic personal health record
06

What researchers measure

Primary outcomes

  1. Systolic blood pressure

    2 seated measures taken using manual sphygmometer by trained research associate

    Time frame: 9 months

  2. Diastolic blood pressure

    2 seated measures taken using manual sphygmometer by trained research associate

    Time frame: 9 months

Secondary outcomes

  1. patient activation

    Patients complete the validated paper-and-pencil Patient Activation Measure (PAM) developed by Judy Hibbard. The instrument assesses the degree to which a patient is "activated," that is the degree to which they are an active agent in their own health care, e.g. ask questions of their health care provider.

    Time frame: 9 months

  2. Patient satisfaction with care

    Consumer Assessment of Health care--group and clinician survey Patient assessment of chronic care Post study interviews

    Time frame: 9 months

  3. adherence to guidelines

    chart audit of patient care

    Time frame: 9 months

07

Study locations

1 site
  • Georgia Health Sciences University
    Augusta, Georgia 30912, United States
08

References and documents

Publications

  • Wagner PJ, Dias J, Howard S, Kintziger KW, Hudson MF, Seol YH, Sodomka P. Personal health records and hypertension control: a randomized trial. J Am Med Inform Assoc. 2012 Jul-Aug;19(4):626-34. doi: 10.1136/amiajnl-2011-000349. Epub 2012 Jan 10. PubMed 22234404 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 17, 2011, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT01317537
Lead sponsor
Augusta University
Collaborators
Agency for Healthcare Research and Quality (AHRQ), Cerner Corporation, The Institute for Patient- and Family-Centered Care
First posted
Mar 17, 2011
Start date
Sep 2007
Primary completion
Jul 2010
Completion
Jul 2010
Last update
Mar 17, 2011

Study contacts

Peggy J Wagner, PhD
principal investigator · Augusta University

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2011. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion